SANLORENZO, Martina
SANLORENZO, Martina
1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed?
2012-01-01 Simone Ribero; Pietro Quaglino; Martina Sanlorenzo; Simona Osella-Abate; Federica Marenco; Tiziana Nardò; Giuseppe Macripò; Maria Teresa Fierro; Maria Grazia Bernengo
A meta-analysis of melanoma risk in industrial workers
2018-01-01 Vujic, Igor; Gandini, Sara; Stanganelli, Ignazio; Fierro, Maria T; Rappersberger, Klemens; Sibilia, Maria; Tosti, Giulio; Ferrucci, Pier F; Caini, Saverio; De Felici, Maria B; Pagliarello, Calogero; Quaglino, Pietro; Sanlorenzo, Martina
Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies
2017-01-01 Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Donini, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis
2015-01-01 Ribero, Simone; Gualano, Maria Rosaria; Osella-Abate, Simona; Scaioli, Giacomo; Bert, Fabrizio; Sanlorenzo, Martina; Balagna, Elena; Fierro, Maria Teresa; Macripò, Giuseppe; Sapino, Anna; Siliquini, Roberta; Quaglino, Pietro
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody
2018-01-01 Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Leuci, Valeria; Rotolo, Ramona; Donini, Chiara; Basiricò, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Sibilia, Maria; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario
Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma.
2014-01-01 Sanlorenzo M; Choudhry A; Vujic I; Posch C; Chong K; Johnston K; Meier M; Osella-Abate S; Quaglino P; Daud A; Algazi A; Rappersberger K; Ortiz-Urda S.
Corrigendum: Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium (Annals of Oncology (2017) 28 (2517-2525) DOI: 10.1093/annonc/mdx352)
2019-01-01 Quaglino, P.; Maule, M.; Prince, H.M.; Porcu, P.; Horwitz, S.; Duvic, M.; Talpur, R.; Vermeer, M.; Bagot, M.; Guitart, J.; Papadavid, E.; Sanches, J.A.; Hodak, E.; Sugaya, M.; Berti, E.; Ortiz-Romero, P.; Pimpinelli, N.; Servitje, O.; Pileri, A.; Zinzani, P.L.; Estrach, T.; Knobler, R.; Stadler, R.; Fierro, M.T.; Alberti Violetti, S.; Amitay-Laish, I.; Antoniou, C.; Astrua, C.; Chaganti, S.; Child, F.; Combalia, A.; Fabbro, S.; Fava, P.; Grandi, V.; Jonak, C.; Martinez-Escala, E.; Kheterpal, M.; Kim, E.J.; McCormack, C.; Miyagaki, T.; Miyashiro, D.; Morris, S.; Muniesa, C.; Nikolaou, V.; Ognibene, G.; Onida, F.; Osella-Abate, S.; Porkert, S.; Postigo-Llorente, C.; Ram-Wolff, C.; Ribero, S.; Rogers, K.; Sanlorenzo, M.; Stranzenbach, R.; Spaccarelli, N.; Stevens, A.; Zugna, D.; Rook, A.H.; Geskin, L.J.; Willemze, R.; Whittaker, S.; Hoppe, R.; Scarisbrick, J.; Kim, Y.
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells
2017-01-01 Gammaitoni L; Giraudo L ; Macagno M; Leuci V; Mesiano G; Rotolo R; Sassi F; Sanlorenzo M; Zaccagna A; Pisacane A; Senetta R; Cangemi M; Cattaneo G; Martin V; Coha V; Gallo S; Pignochino Y; Sapino A; Grignani G; Carnevale-Schianca F; Aglietta M; Sangiolo D
Efficacy of electrochemotherapy for eruptive legs keratoacanthomas
2016-01-01 Ribero, Simone; Balagna, E; Sportoletti Baduel, E; Picciotto, F; Sanlorenzo, Martina; Fierro, Maria Teresa; Quaglino, Pietro; Macripo, G.
False negative rate in patients with cutaneous melanoma submitted to sentinel lymph node biopsy
2012-01-01 Simone Ribero; Simona Osella-Abate; Paola Savoia; Virginia Caliendo; Martina Sanlorenzo; Pietro Quaglino; Giuseppe Macripò; Maria Grazia Bernengo.
Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients.
2013-01-01 Ribero S; Osella-Abate S; Sanlorenzo M; Savoia P; Astrua C; Cavaliere G; Tomasini C; Senetta R; Macripò G; Bernengo MG; Quaglino P.
Fluorescence-Advanced-Videodermatoscopy (FAV): a new method for in-vivo skin evaluation
2017-01-01 Sanlorenzo Martina, Vujic Igor, De Giorgi Vincenzo, Tomasini Carlo, Deboli Tommaso, Quaglino Pietro, Fierro Maria Teresa, Broganelli Paolo
Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review
2022-01-01 Sanlorenzo, M; Ribero, S; Osella Abate, S; Mariani, S; Strignano, P; Salizzoni, M; Savoia, P; Fierro, M T; Quaglino, P
Giornale italiano di Dermatologia e Venereologia
2012-01-01 S. Ribero; P. Quaglino; M. Sanlorenzo; S. Osella-Abate; F. Marenco; M. T. Fierro; M.G. Bernengo
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium
2017-01-01 Quaglino, Pietro*; Maule, M.; Prince, H.M.; Porcu, P.; Horwitz, S.; Duvic, M.; Talpur, R.; Vermeer, M.; Bagot, M.; Guitart, J.; Papadavid, E.; Sanches, J.A.; Hodak, E.; Sugaya, M.; Berti, E.; Ortiz-Romero, P.; Pimpinelli, N.; Servitje, O.; Pileri, A.; Zinzani, P.L.; Estrach, T.; Knobler, R.; Stadler, R.; Fierro, M.T.; Alberti Violetti, S.; Amitay-Laish, I.; Antoniou, C.; Astrua, C.; Chaganti, S.; Child, F.; Combalia, A.; Fabbro, S.; Fava, P.; Grandi, V.; Jonak, C.; Martinez-Escala, E.; Kheterpal, M.; Kim, E.J.; McCormack, C.; Miyagaki, T.; Miyashiro, D.; Morris, S.; Muniesa, C.; Nikolaou, V.; Ognibene, G.; Onida, F.; Osella-Abate, S.; Porkert, S.; Postigo-Llorente, C.; Ram-Wolff, C.; Ribero, S.; Rogers, K.; Sanlorenzo, M.; Stranzenbach, R.; Spaccarelli, N.; Stevens, A.; Zugna, D.; Rook, A.H.; Geskin, L.J.; Willemze, R.; Whittaker, S.; Hoppe, R.; Scarisbrick, J.; Kim, Y.
Il melanoma in giovane età
2012-01-01 S. Ribero; P. Quaglino; V. Caliendo; M. Grassi; D. Lauro; M. Sanlorenzo; G. Macripò; M. G. Bernengo
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
2021-01-01 Roccuzzo G.; Giordano S.; Fava P.; Pileri A.; Guglielmo A.; Tonella L.; Sanlorenzo M.; Ribero S.; Fierro M.T.; Quaglino P.
Melanoma immunotherapy.
2014-01-01 Sanlorenzo M; Vujic I; Posch C; Dajee A; Yen A; Kim S; Ashworth M; Rosenblum MD; Algazi A; Osella-Abate S; Quaglino P; Daud A; Ortiz-Urda S.
Melanoma in patients younger than 20 years.
2013-01-01 Sanlorenzo M; Ribero S; Osella-Abate S; Balagna EM; Caliendo V; Macripò G; Bernengo MG; Quaglino P.
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome
2015-01-01 Sanlorenzo, Martina; Osella-Abate, Simona; Ribero, Simone; Marenco, Federica; Nardò, Tiziana; Fierro, Maria Teresa; Novelli, Mauro; Cervetti, Ornella; Bernengo, Maria Grazia; Quaglino, Pietro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed? | 2012 | Simone Ribero; Pietro Quaglino; Martina Sanlorenzo; Simona Osella-Abate; Federica Marenco; Tiziana Nardò; Giuseppe Macripò; Maria Teresa Fierro; Maria Grazia Bernengo | |
| A meta-analysis of melanoma risk in industrial workers | 2018 | Vujic, Igor; Gandini, Sara; Stanganelli, Ignazio; Fierro, Maria T; Rappersberger, Klemens; Sibilia, Maria; Tosti, Giulio; Ferrucci, Pier F; Caini, Saverio; De Felici, Maria B; Pagliarello, Calogero; Quaglino, Pietro; Sanlorenzo, Martina | |
| Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies | 2017 | Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Donini, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario | |
| Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis | 2015 | Ribero, Simone; Gualano, Maria Rosaria; Osella-Abate, Simona; Scaioli, Giacomo; Bert, Fabrizio; Sanlorenzo, Martina; Balagna, Elena; Fierro, Maria Teresa; Macripò, Giuseppe; Sapino, Anna; Siliquini, Roberta; Quaglino, Pietro | |
| BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody | 2018 | Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Leuci, Valeria; Rotolo, Ramona; Donini, Chiara; Basiricò, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Sibilia, Maria; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario | |
| Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma. | 2014 | Sanlorenzo M; Choudhry A; Vujic I; Posch C; Chong K; Johnston K; Meier M; Osella-Abate S; Quaglino P; Daud A; Algazi A; Rappersberger K; Ortiz-Urda S. | |
| Corrigendum: Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium (Annals of Oncology (2017) 28 (2517-2525) DOI: 10.1093/annonc/mdx352) | 2019 | Quaglino, P.; Maule, M.; Prince, H.M.; Porcu, P.; Horwitz, S.; Duvic, M.; Talpur, R.; Vermeer, M.; Bagot, M.; Guitart, J.; Papadavid, E.; Sanches, J.A.; Hodak, E.; Sugaya, M.; Berti, E.; Ortiz-Romero, P.; Pimpinelli, N.; Servitje, O.; Pileri, A.; Zinzani, P.L.; Estrach, T.; Knobler, R.; Stadler, R.; Fierro, M.T.; Alberti Violetti, S.; Amitay-Laish, I.; Antoniou, C.; Astrua, C.; Chaganti, S.; Child, F.; Combalia, A.; Fabbro, S.; Fava, P.; Grandi, V.; Jonak, C.; Martinez-Escala, E.; Kheterpal, M.; Kim, E.J.; McCormack, C.; Miyagaki, T.; Miyashiro, D.; Morris, S.; Muniesa, C.; Nikolaou, V.; Ognibene, G.; Onida, F.; Osella-Abate, S.; Porkert, S.; Postigo-Llorente, C.; Ram-Wolff, C.; Ribero, S.; Rogers, K.; Sanlorenzo, M.; Stranzenbach, R.; Spaccarelli, N.; Stevens, A.; Zugna, D.; Rook, A.H.; Geskin, L.J.; Willemze, R.; Whittaker, S.; Hoppe, R.; Scarisbrick, J.; Kim, Y. | |
| Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells | 2017 | Gammaitoni L; Giraudo L ; Macagno M; Leuci V; Mesiano G; Rotolo R; Sassi F; Sanlorenzo M; Zaccagna A; Pisacane A; Senetta R; Cangemi M; Cattaneo G; Martin V; Coha V; Gallo S; Pignochino Y; Sapino A; Grignani G; Carnevale-Schianca F; Aglietta M; Sangiolo D | |
| Efficacy of electrochemotherapy for eruptive legs keratoacanthomas | 2016 | Ribero, Simone; Balagna, E; Sportoletti Baduel, E; Picciotto, F; Sanlorenzo, Martina; Fierro, Maria Teresa; Quaglino, Pietro; Macripo, G. | |
| False negative rate in patients with cutaneous melanoma submitted to sentinel lymph node biopsy | 2012 | Simone Ribero; Simona Osella-Abate; Paola Savoia; Virginia Caliendo; Martina Sanlorenzo; Pietro Quaglino; Giuseppe Macripò; Maria Grazia Bernengo. | |
| Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients. | 2013 | Ribero S; Osella-Abate S; Sanlorenzo M; Savoia P; Astrua C; Cavaliere G; Tomasini C; Senetta R; Macripò G; Bernengo MG; Quaglino P. | |
| Fluorescence-Advanced-Videodermatoscopy (FAV): a new method for in-vivo skin evaluation | 2017 | Sanlorenzo Martina, Vujic Igor, De Giorgi Vincenzo, Tomasini Carlo, Deboli Tommaso, Quaglino Pietro, Fierro Maria Teresa, Broganelli Paolo | |
| Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review | 2022 | Sanlorenzo, M; Ribero, S; Osella Abate, S; Mariani, S; Strignano, P; Salizzoni, M; Savoia, P; Fierro, M T; Quaglino, P | |
| Giornale italiano di Dermatologia e Venereologia | 2012 | S. Ribero; P. Quaglino; M. Sanlorenzo; S. Osella-Abate; F. Marenco; M. T. Fierro; M.G. Bernengo | |
| Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium | 2017 | Quaglino, Pietro*; Maule, M.; Prince, H.M.; Porcu, P.; Horwitz, S.; Duvic, M.; Talpur, R.; Vermeer, M.; Bagot, M.; Guitart, J.; Papadavid, E.; Sanches, J.A.; Hodak, E.; Sugaya, M.; Berti, E.; Ortiz-Romero, P.; Pimpinelli, N.; Servitje, O.; Pileri, A.; Zinzani, P.L.; Estrach, T.; Knobler, R.; Stadler, R.; Fierro, M.T.; Alberti Violetti, S.; Amitay-Laish, I.; Antoniou, C.; Astrua, C.; Chaganti, S.; Child, F.; Combalia, A.; Fabbro, S.; Fava, P.; Grandi, V.; Jonak, C.; Martinez-Escala, E.; Kheterpal, M.; Kim, E.J.; McCormack, C.; Miyagaki, T.; Miyashiro, D.; Morris, S.; Muniesa, C.; Nikolaou, V.; Ognibene, G.; Onida, F.; Osella-Abate, S.; Porkert, S.; Postigo-Llorente, C.; Ram-Wolff, C.; Ribero, S.; Rogers, K.; Sanlorenzo, M.; Stranzenbach, R.; Spaccarelli, N.; Stevens, A.; Zugna, D.; Rook, A.H.; Geskin, L.J.; Willemze, R.; Whittaker, S.; Hoppe, R.; Scarisbrick, J.; Kim, Y. | |
| Il melanoma in giovane età | 2012 | S. Ribero; P. Quaglino; V. Caliendo; M. Grassi; D. Lauro; M. Sanlorenzo; G. Macripò; M. G. Bernengo | |
| Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives | 2021 | Roccuzzo G.; Giordano S.; Fava P.; Pileri A.; Guglielmo A.; Tonella L.; Sanlorenzo M.; Ribero S.; Fierro M.T.; Quaglino P. | |
| Melanoma immunotherapy. | 2014 | Sanlorenzo M; Vujic I; Posch C; Dajee A; Yen A; Kim S; Ashworth M; Rosenblum MD; Algazi A; Osella-Abate S; Quaglino P; Daud A; Ortiz-Urda S. | |
| Melanoma in patients younger than 20 years. | 2013 | Sanlorenzo M; Ribero S; Osella-Abate S; Balagna EM; Caliendo V; Macripò G; Bernengo MG; Quaglino P. | |
| Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome | 2015 | Sanlorenzo, Martina; Osella-Abate, Simona; Ribero, Simone; Marenco, Federica; Nardò, Tiziana; Fierro, Maria Teresa; Novelli, Mauro; Cervetti, Ornella; Bernengo, Maria Grazia; Quaglino, Pietro |